These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20521937)

  • 1. Mechanisms of antifungal drug resistance in Candida dubliniensis.
    Coleman DC; Moran GP; McManus BA; Sullivan DJ
    Future Microbiol; 2010 Jun; 5(6):935-49. PubMed ID: 20521937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azole susceptibility and resistance in Candida dubliniensis.
    Pinjon E; Moran GP; Coleman DC; Sullivan DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.
    Sullivan DJ; Moran GP; Pinjon E; Al-Mosaid A; Stokes C; Vaughan C; Coleman DC
    FEMS Yeast Res; 2004 Jan; 4(4-5):369-76. PubMed ID: 14734017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains.
    Schubert S; Rogers PD; Morschhäuser J
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4274-80. PubMed ID: 18809934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.
    Fleischhacker M; Pasligh J; Moran G; Ruhnke M
    J Clin Microbiol; 2010 May; 48(5):1643-50. PubMed ID: 20200288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isogenic strain construction and gene targeting in Candida dubliniensis.
    Staib P; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
    J Bacteriol; 2001 May; 183(9):2859-65. PubMed ID: 11292806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDR1-mediated drug resistance in Candida dubliniensis.
    Wirsching S; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral yeast carriage in HIV-infected and non-infected populations in Rosario, Argentina.
    Luque AG; Biasoli MS; Tosello ME; Binolfi A; Lupo S; Magaró HM
    Mycoses; 2009 Jan; 52(1):53-9. PubMed ID: 18498298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait.
    Asadzadeh M; Ahmad S; Al-Sweih N; Khan Z
    PLoS One; 2017; 12(4):e0175269. PubMed ID: 28380072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of Candida dubliniensis strains using heat tolerance tests, morphological characteristics and molecular methods].
    Arikan S; Darka O; Hasçelik G; Günalp A
    Mikrobiyol Bul; 2003 Jan; 37(1):49-57. PubMed ID: 12838678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of cell surface hydrophobicity and biofilm formation among genotypes of Candida albicans and Candida dubliniensis under antifungal treatment.
    Borecká-Melkusová S; Bujdáková H
    Can J Microbiol; 2008 Sep; 54(9):718-24. PubMed ID: 18772934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.
    Al Mosaid A; Sullivan DJ; Polacheck I; Shaheen FA; Soliman O; Al Hedaithy S; Al Thawad S; Kabadaya M; Coleman DC
    J Clin Microbiol; 2005 Aug; 43(8):4026-36. PubMed ID: 16081946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distributions and antifungal susceptibility of Candida species from mucosal sites in HIV positive patients.
    Badiee P; Alborzi A; Davarpanah MA; Shakiba E
    Arch Iran Med; 2010 Jul; 13(4):282-7. PubMed ID: 20597560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida dubliniensis: an emerging opportunistic pathogen.
    Sullivan D; Coleman D
    Curr Top Med Mycol; 1997 Dec; 8(1-2):15-25. PubMed ID: 9504063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Candida dubliniensis: a novel emerging species].
    Anane S; Kallel K; Kaouech E; Belhaj S; Chaker E
    Ann Biol Clin (Paris); 2007; 65(1):13-9. PubMed ID: 17264034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait.
    Ahmad S; Mokaddas E; Al-Sweih N; Khan ZU
    Med Princ Pract; 2005; 14 Suppl 1():77-83. PubMed ID: 16103717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.